Intelgenx Technologies (FRA:0IL) FCF Margin % : -1,642.50% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Intelgenx Technologies FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Intelgenx Technologies's Free Cash Flow for the three months ended in Mar. 2024 was €-2.63 Mil. Intelgenx Technologies's Revenue for the three months ended in Mar. 2024 was €0.16 Mil. Therefore, Intelgenx Technologies's FCF Margin % for the quarter that ended in Mar. 2024 was -1,642.50%.

As of today, Intelgenx Technologies's current FCF Yield % is -24.77%.

The historical rank and industry rank for Intelgenx Technologies's FCF Margin % or its related term are showing as below:

FRA:0IL' s FCF Margin % Range Over the Past 10 Years
Min: -1175.74 Med: -427.84 Max: -11.44
Current: -686.93

During the past 13 years, the highest FCF Margin % of Intelgenx Technologies was -11.44%. The lowest was -1175.74%. And the median was -427.84%.

FRA:0IL's FCF Margin % is ranked worse than
70.84% of 1046 companies
in the Biotechnology industry
Industry Median: -144.01 vs FRA:0IL: -686.93

Intelgenx Technologies FCF Margin % Historical Data

The historical data trend for Intelgenx Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelgenx Technologies FCF Margin % Chart

Intelgenx Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-1,175.45

-381.40

-474.52

-1,029.99

-645.12

Intelgenx Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-1,445.03	-1,751.22	-454.70	-138.11	-1,642.50

Competitive Comparison of Intelgenx Technologies's FCF Margin %

For the Biotechnology subindustry, Intelgenx Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intelgenx Technologies's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intelgenx Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Intelgenx Technologies's FCF Margin % falls into.

Intelgenx Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Intelgenx Technologies's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-6.148	/	0.953
	=	-645.12 %

Intelgenx Technologies's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-2.628	/	0.16
	=	-1,642.50 %

Intelgenx Technologies FCF Margin % Related Terms

Thank you for viewing the detailed overview of Intelgenx Technologies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Intelgenx Technologies (FRA:0IL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intelgenx Technologies Corp (FRA:0IL) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

IGXT:USA 0IL:Germany IGX:Canada

Address

6420 Abrams, Ville Saint Laurent, QC, CAN, H4S 1Y2

Website

https://www.intelgenx.com

Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.

Intelgenx Technologies (FRA:0IL) Headlines

No Headlines